Showing results (141-150 of 147) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The Lancet. Rheumatology|April 4, 2022
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trialMeiLan K Han, Martti Antila, Joachim H Ficker, et al.Frontiers in Medicine|August 2, 2021
Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical TrialXu Shu, Zhenhua Zhu, Yu Fu, et al.World Journal of Gastroenterology|August 30, 2014
Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infectionYong Xie, Yin Zhu, Hong Zhou, et al.The Lancet. Microbe|December 21, 2024
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trialYi Hu, Zhen-Yu Zhang, Fen Wang, et al.Journal of Hematology & Oncology|November 5, 2022
FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective studyShengbing Zhao, Shuling Wang, Peng Pan, et al.Journal of Gastroenterology and Hepatology|March 5, 2025
Risk Factors Analysis and Predictive Model Construction for Autoimmune Gastritis: A Nationwide Multicenter Case-Control Study in ChinaXin-Yue Ma, Yu Hao, Yuan-Hong Xie, et al.Journal of Gastroenterology and Hepatology|September 7, 2022
Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trialNian-di Tan, Xiao-Wei Liu, Cheng-Xia Liu, et al.Pageof 15